Search





Search





Markets
/
Stocks
/
kymr
/

Kymera Therapeutics Inc

KYMR

Add to Watchlist

103.400USD

-3.610-3.37%

Close 07-31 16:00（ET）Quotes delayed by 15 min

8.50BMarket Cap

LossP/E TTM

Kymera Therapeutics Inc

103.400

-3.610-3.37%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

KYMR Cash Flow Statement

You can access the annual and quarterly cash flow statements of Kymera Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2019Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-12.24%-88.84M

-8.03%-66.75M

45.99%-27.11M

-39.47%-59.88M

-99.92%-79.15M

-867.98%-61.78M

-58.59%-50.19M

-21.78%-42.94M

9.95%-39.59M

120.35%8.04M

7.65%-31.65M

9.57%-35.26M

-9.12%-43.97M

-3.09%-39.54M

8.03%-34.27M

-27.77%-38.98M

-76.55%-40.30M

-91.11%-38.35M

-128.30%-37.26M

---30.51M

---22.82M

-85.80%-20.07M

--131.67M

---10.80M

Net income from continuing operations

-5.57%-69.23M

-22.94%-86.98M

-31.51%-82.17M

-82.15%-76.61M

-35.06%-65.58M

-392.43%-70.75M

-18.20%-62.49M

-8.41%-42.06M

-18.64%-48.56M

58.79%-14.37M

-22.94%-52.87M

3.62%-38.80M

-11.57%-40.93M

-2.85%-34.87M

-50.45%-43.00M

-63.25%-40.26M

-180.57%-36.68M

-167.24%-33.90M

-257.86%-28.58M

---24.66M

---13.07M

-10.18%-12.69M

---7.99M

---11.51M

Operating gains losses

-1.27%2.02M

2.32%2.03M

202.16%6.00M

7.53%2.08M

-67.93%2.05M

123.01%1.99M

122.01%1.99M

115.33%1.94M

626.51%6.39M

8.92%891.00K

16.69%895.00K

27.66%900.00K

27.95%879.00K

18.72%818.00K

14.31%767.00K

27.72%705.00K

41.65%687.00K

38.63%689.00K

36.94%671.00K

--552.00K

--485.00K

37.67%497.00K

--490.00K

--361.00K

Other non-cash items

-8.12%-2.73M

37.40%-2.04M

39.61%-2.19M

47.25%-2.12M

17.81%-2.52M

-157.45%-3.27M

-197.70%-3.62M

-183.77%-4.02M

-131.67%-3.07M

-40.22%-1.27M

-1998.28%-1.22M

-309.31%-1.42M

-212.85%-1.33M

-155.32%-905.00K

-103.49%-58.00K

-45.05%677.00K

-8.13%1.18M

4.14%1.64M

1409.09%1.66M

--1.23M

--1.28M

1315.32%1.57M

--110.00K

--111.00K

Change in working capital

-27.74%-34.91M

263.14%5.79M

3750.57%35.45M

110.29%1.35M

-332.63%-27.32M

-129.86%-3.55M

-109.82%-971.00K

-84.44%-13.13M

47.27%-6.32M

188.14%11.89M

1039.83%9.89M

26.84%-7.12M

10.25%-11.98M

12.69%-13.49M

94.29%-1.05M

27.16%-9.73M

9.11%-13.35M

-37.04%-15.46M

-113.47%-18.42M

---13.36M

---14.68M

-19685.96%-11.28M

--136.73M

---57.00K

-Change in receivables

100.00%0.00

-100.00%0.00

10262.69%40.00M

-6216.21%-20.00M

-213.87%-19.05M

102.47%370.00K

12.21%386.00K

140.77%327.00K

2236.91%16.73M

-4430.92%-14.98M

167.06%344.00K

27.49%-802.00K

30.59%-783.00K

-75.94%346.00K

23.32%-513.00K

-233.25%-1.11M

-274.75%-1.13M

267.99%1.44M

-15.94%-669.00K

--830.00K

---301.00K

---856.00K

---577.00K

--0.00

-Change in prepaid expenses

-228.42%-3.56M

89.77%-322.00K

107.23%266.00K

-646.93%-5.08M

192.38%2.78M

-230.29%-3.15M

-857.81%-3.68M

139.48%929.00K

-83.12%-3.00M

603.54%2.42M

66.37%-384.00K

-293.50%-2.35M

-180.03%-1.64M

83.72%-480.00K

-16.89%-1.14M

67.72%1.22M

28.19%-586.00K

-24.07%-2.95M

-231.67%-977.00K

--725.00K

---816.00K

-1220.00%-2.38M

--742.00K

---180.00K

-Change in other current assets

-8.62%615.00K

-30.80%-1.69M

-157.11%-1.45M

-338.97%-2.04M

8.72%673.00K

-144.26%-1.29M

245.63%2.53M

-7.09%852.00K

-45.61%619.00K

439.81%2.92M

450.38%732.00K

627.78%917.00K

856.30%1.14M

54.26%-859.00K

23.15%133.00K

23.53%126.00K

25.26%119.00K

-2335.71%-1.88M

-88.99%108.00K

--102.00K

--95.00K

-90.20%84.00K

--981.00K

--857.00K

-Change in other current liabilities

-1052.90%-32.21M

55.79%-3.04M

-26.94%-2.47M

218.40%29.11M

64.98%-2.79M

-166.63%-6.87M

-233.16%-1.95M

-95.51%-24.59M

-37.88%-7.98M

179.27%10.31M

91.44%-585.00K

-27.49%-12.58M

25.89%-5.79M

10.99%-13.01M

62.96%-6.84M

46.74%-9.86M

55.83%-7.81M

-24.66%-14.61M

-113.57%-18.46M

---18.52M

---17.68M

-548.04%-11.72M

--136.04M

---1.81M

Cash from non-recurring investing activities

Cash from operating activities

-12.24%-88.84M

-8.03%-66.75M

45.99%-27.11M

-39.47%-59.88M

-99.92%-79.15M

-867.98%-61.78M

-58.59%-50.19M

-21.78%-42.94M

9.95%-39.59M

120.35%8.04M

7.65%-31.65M

9.57%-35.26M

-9.12%-43.97M

-3.09%-39.54M

8.03%-34.27M

-27.77%-38.98M

-76.55%-40.30M

-91.11%-38.35M

-128.30%-37.26M

---30.51M

---22.82M

-85.80%-20.07M

--131.67M

---10.80M

Investing cash flow

Net cash from continuing investing activities

-7.07%434.00K

-88.68%106.00K

195.77%181.00K

-85.18%695.00K

-93.69%467.00K

-91.95%936.00K

-102.34%-189.00K

-56.45%4.69M

84.63%7.40M

3016.62%11.63M

548.31%8.08M

1365.03%10.77M

731.74%4.01M

-25.55%373.00K

307.19%1.25M

17.41%735.00K

193.90%482.00K

-65.14%501.00K

-87.30%306.00K

--626.00K

--164.00K

622.11%1.44M

--2.41M

--199.00K

Capital expenditures

-7.07%434.00K

-88.68%106.00K

--181.00K

-85.18%695.00K

-93.69%467.00K

-91.95%936.00K

----

-56.45%4.69M

84.63%7.40M

3016.62%11.63M

548.31%8.08M

1365.03%10.77M

731.74%4.01M

-25.55%373.00K

307.19%1.25M

17.41%735.00K

193.90%482.00K

-65.14%501.00K

-87.30%306.00K

--626.00K

--164.00K

622.11%1.44M

--2.41M

--199.00K

Net cash flow from disposal of fixed assets

-7.07%434.00K

-88.68%106.00K

195.77%181.00K

-85.18%695.00K

-93.69%467.00K

-91.95%936.00K

-102.34%-189.00K

-56.45%4.69M

84.63%7.40M

3016.62%11.63M

548.31%8.08M

1365.03%10.77M

731.74%4.01M

-25.55%373.00K

307.19%1.25M

17.41%735.00K

193.90%482.00K

-65.14%501.00K

-87.30%306.00K

--626.00K

--164.00K

622.11%1.44M

--2.41M

--199.00K

Net cash flow from investment products

-390.14%-142.41M

-667.29%-394.29M

-48.93%-235.12M

198.64%60.72M

115.19%49.08M

127.31%69.50M

-330.17%-157.87M

-56.38%20.33M

-1230.36%-323.20M

162.03%30.58M

289.29%68.59M

-43.53%46.61M

8.53%28.59M

26.99%-49.29M

73.47%-36.23M

34.54%82.54M

-40.78%26.34M

-2544.65%-67.52M

58.86%-136.56M

--61.35M

--44.49M

-104.11%-2.55M

---331.91M

--62.16M

Net cash flow from other investing activities

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-393.82%-142.84M

-675.19%-394.40M

-49.23%-235.30M

283.72%60.02M

114.70%48.62M

261.80%68.57M

-360.58%-157.68M

-56.35%15.64M

-1444.81%-330.61M

138.16%18.95M

261.44%60.51M

-56.19%35.84M

-4.95%24.58M

26.98%-49.67M

72.61%-37.48M

34.72%81.80M

-41.65%25.86M

-1604.74%-68.02M

59.06%-136.86M

--60.72M

--44.32M

-106.44%-3.99M

---334.32M

--61.96M

Financing cash flow

Cash flow from continuous financing activities

7174.81%18.77M

25405.21%705.22M

-84.25%39.51M

17302.69%245.73M

-99.93%258.00K

42.97%2.77M

121904.85%250.92M

8.20%1.41M

30422.52%353.76M

-0.97%1.93M

-100.14%-206.00K

258.52%1.30M

526.49%1.16M

-4.92%1.95M

-38.83%150.50M

-77.14%364.00K

-68.91%185.00K

660.74%2.05M

25.35%246.04M

--1.59M

--595.00K

-98.72%270.00K

--196.28M

--21.09M

Net cash flow from debt Issuance/repayment

-53.43%-425.00K

-41.98%-416.00K

34.63%-419.00K

-8.52%-382.00K

4.48%-277.00K

-131.68%-293.00K

-88.53%-641.00K

-5.39%-352.00K

11.31%-290.00K

403.28%925.00K

-16.44%-340.00K

-24.16%-334.00K

-23.86%-327.00K

-95.51%-305.00K

17.05%-292.00K

-44.62%-269.00K

-70.32%-264.00K

-2.63%-156.00K

-222.94%-352.00K

---186.00K

---155.00K

-28.81%-152.00K

---109.00K

---118.00K

Net cash flow from common stock issuance/repurchase

----

--656.23M

-85.65%35.38M

--237.29M

-100.00%0.00

--0.00

--246.51M

--0.00

--350.11M

--0.00

----

--0.00

-37.78%149.82M

----

-100.00%0.00

31.76%240.79M

----

--398.00K

--182.75M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

--0.00

--21.18M

Proceeds from stock option exercised by employees

3487.66%19.19M

1515.60%49.41M

-9.91%4.55M

399.66%8.81M

-86.40%535.00K

203.07%3.06M

3670.90%5.05M

7.63%1.76M

164.67%3.93M

-55.31%1.01M

-86.10%134.00K

158.93%1.64M

230.96%1.49M

0.85%2.26M

-70.39%964.00K

-64.40%633.00K

-60.85%449.00K

9229.17%2.24M

2887.16%3.26M

--1.78M

--1.15M

-14.29%24.00K

--109.00K

--28.00K

Net cash flow from other financing activities

----

--656.23M

----

100.00%0.00

-100.00%0.00

--0.00

100.00%0.00

---29.00K

-82.65%2.35M

--0.00

---397.00K

--0.00

--13.53M

----

Net cash from non-recurrent financing activities

Net cash from financing activities

7174.81%18.77M

25405.21%705.22M

-84.25%39.51M

17302.69%245.73M

-99.93%258.00K

42.97%2.77M

121904.85%250.92M

8.20%1.41M

30422.52%353.76M

-0.97%1.93M

-100.14%-206.00K

258.52%1.30M

526.49%1.16M

-4.92%1.95M

-38.83%150.50M

-77.14%364.00K

-68.91%185.00K

660.74%2.05M

25.35%246.04M

--1.59M

--595.00K

-98.72%270.00K

--196.28M

--21.09M

Net cash flow

Beginning cash balance

187.83%362.81M

1.92%118.74M

365.11%341.64M

-3.59%95.77M

8.87%126.05M

34.15%116.50M

26.24%73.45M

76.44%99.33M

55.36%115.78M

-46.32%86.85M

-29.92%58.19M

41.30%56.30M

37.77%74.52M

2.12%161.77M

-4.01%83.03M

-27.14%39.84M

65.96%54.09M

180.96%158.41M

37.81%86.49M

--54.69M

--32.59M

918.08%56.38M

--62.76M

--5.54M

Current period cash flow changes

-603.21%-212.91M

2456.02%244.07M

-617.79%-222.90M

1049.94%245.86M

-84.14%-30.28M

-66.99%9.55M

50.21%43.05M

-1470.87%-25.88M

9.78%-16.44M

133.16%28.93M

-63.61%28.66M

-95.63%1.89M

-27.92%-18.23M

16.36%-87.25M

9.50%78.75M

35.78%43.18M

-164.48%-14.25M

-338.53%-104.32M

1227.40%71.92M

--31.80M

--22.09M

-132.92%-23.79M

---6.38M

--72.25M

Ending cash balance

56.52%149.90M

187.83%362.81M

1.92%118.74M

365.11%341.64M

-3.59%95.77M

8.87%126.05M

34.15%116.50M

26.24%73.45M

76.44%99.33M

55.35%115.78M

-46.32%86.84M

-29.92%58.19M

41.30%56.30M

37.77%74.53M

2.12%161.77M

-4.01%83.03M

-27.14%39.84M

65.96%54.09M

180.96%158.41M

--86.49M

--54.69M

-58.10%32.59M

--56.38M

--77.79M

Free cash flow

-12.13%-89.27M

-6.59%-66.85M

45.62%-27.29M

-27.20%-60.58M

-69.42%-79.62M

-1651.96%-62.72M

-26.34%-50.19M

-3.48%-47.63M

2.05%-46.99M

91.03%-3.58M

-11.85%-39.73M

-15.87%-46.02M

-17.66%-47.98M

-2.72%-39.91M

5.46%-35.52M

-27.57%-39.72M

-77.39%-40.78M

-80.67%-38.85M

-129.06%-37.57M

---31.14M

---22.99M

-95.50%-21.50M

--129.26M

---11.00M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Kymera Therapeutics Inc Generate?



Kymera Therapeutics Inc generated -232.89M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Kymera Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Kymera Therapeutics Inc's operating cash flow increased by -19.74% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Kymera Therapeutics Inc Spend on Capital Expenditures?



Kymera Therapeutics Inc spent 1.45M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Kymera Therapeutics Inc's Financing Cash Flow Changed?



Kymera Therapeutics Inc used 990.71M in financing activities in the latest quarter.

What is free cash flow and why does it matter for KYMR?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Kymera Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -234.34M reflecting a -13.02% change from the previous year.